farnesiferol-c and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

farnesiferol-c has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for farnesiferol-c and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

Article	Year
Farnesiferol C Induces Apoptosis in Chronic Myelogenous Leukemia Cells as an Imatinib Sensitizer via Caspase Activation and HDAC (Histone Deacetylase) Inactivation. International journal of molecular sciences, 2019, Nov-06, Volume: 20, Issue:22 Topics: Acetylation; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Coumarins; Enzyme Activation; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; RNA, Messenger	2019

Article

Year

Farnesiferol C Induces Apoptosis in Chronic Myelogenous Leukemia Cells as an Imatinib Sensitizer via Caspase Activation and HDAC (Histone Deacetylase) Inactivation.

International journal of molecular sciences, 2019, Nov-06, Volume: 20, Issue:22

Topics: Acetylation; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Coumarins; Enzyme Activation; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; RNA, Messenger

2019